Refine your search
412 results found
Fasken | Canada | 27 Mar 2023
French Language Requirements: Quebec Publishes Long-Awaited Draft Regulation on Documents Used in Research
The National Assembly adopted Bill 96, An Act respecting French, the official and common language of Québec on May 24, 2022, ushering in new…
Shearman & Sterling LLP | USA | 24 Mar 2023
Southern District Of New York Grants Pharmaceutical Company’s Motion To Dismiss Putative Class Action Alleging Misrepresentations About Contingent Value Right Securities
On March 1, 2023, Judge Jesse Furman of the United States District Court for the Southern District of New York granted a motion to dismiss a putative…
Fasken | Canada | 23 Mar 2023
PAAB Publishes Draft Guidance Document on Use of Real-World Evidence in Advertising
The Pharmaceutical Advertising Advisory Board (“PAAB”) has published a draft guidance document on the use of real-world evidence (“RWE”) in…
McGuireWoods LLP | USA | 20 Mar 2023
Strong margins and recession resistant: the allure of pharma services
The pharmaceutical services industry has piqued the interest of private equity investors over the last five to 10 years as more drugs move into…
Edgeworth Economics | USA | 15 Mar 2023
Don’t Count Out Numerosity
To obtain class certification, the Supreme Court of the United States requires a rigorous analysis under Rule 23. Economists can provide…
King & Wood Mallesons | China | 14 Mar 2023
药品许可交易中的若干风险及其应对
近年来，中国药品许可交易的规模逐渐扩大，据媒体统计从2016年至2021年交易数量和金额持续上升，在2021年达到顶峰（交易数量：356…
Lexology PRO | Central & South America, Chile | 13 Mar 2023
Chile seeks fine against immunity applicant for compliance programme failure
Chile’s antitrust watchdog has urged the country’s specialist competition tribunal to fine a drugmaker €1.3 million for breaching the terms of its compliance programme commitment after blowing the whistle on a 14-year bid-rigging scheme.
Taylor Wessing | European Union | 13 Mar 2023
Judgment of the General Court of 30 November 2022 — Hasco TM v EUIPO — Esi (NATURCAPS)
The use of a trademark for food supplements does not qualify as genuine use for pharmaceutical products according to the General Court (EU) After a…
Bass Berry & Sims PLC | USA | 9 Mar 2023
OIG Approves Free Drug Program for Ultra-Rare Condition in Advisory Opinion 23-02
On February 23, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services issued Advisory Opinion 23-02, approving a…
Bristows | European Union, United Kingdom | 7 Mar 2023
EU and UK reach new agreement on medicines regulation in Northern Ireland
The EU and UK have agreed major changes to the regulation of medicines in Northern Ireland (NI). The package of measures would simplify marketing…
